Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. For 2017, two European Union/European Economic Area (EU/EEA) countries reported six confirmed anthrax cases (Romania reported five cases and Bulgaria one). The remaining 28 reporting countries did not notify any confirmed cases.
Anthrax continues to be an uncommon disease in humans in Europe, with only a few cases reported every year. For 2018, three confirmed anthrax cases were reported, one each in Netherlands, Romania and Spain. Twenty-seven EU/EEA countries notified zero confirmed cases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 July-6 August and includes updates on West Nile virus infection, monkeypox, COVID-19, cholera, diphteria, anthrax, Vibrio growth, Marburg virus disease, mass gatherings at the Birmingham 2022 Commonwealth games, MERS-CoV, and Poliovirus.
In 2020, 13 914 cases of hepatitis C were reported in 28 EU/EEA Member States. Excluding countries that only reported acute cases leaves 13 901 cases, which corresponds to a crude rate of 3.9 cases per 100 000 population.
This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
Anthrax continues to be uncommon in humans in Europe, with only a few cases reported every year. For 2019, one confirmed anthrax case was reported by Hungary. Twenty-nine EU/EEA countries notified zero confirmed cases.